Showing 341 - 360 results of 687 for search '"cirrhosis"', query time: 0.05s Refine Results
  1. 341

    Imaging the Abdominal Manifestations of Cystic Fibrosis by C. D. Gillespie, M. K. O’Reilly, G. N. Allen, S. McDermott, V. O. Chan, C. A. Ridge

    Published 2017-01-01
    “…Subsequently, there is increasing focus on the impact of abdominal disease on quality of life and survival. Liver cirrhosis is the most important extrapulmonary cause of death in CF, yet significant challenges remain in the diagnosis of CF related liver disease. …”
    Get full text
    Article
  2. 342

    Early Kasai portoenterostomy in a 9-day-old newborn with extrahepatic biliary atresia: a case report highlighting improved prognosis with prompt intervention by Mortada H.F. El-Shabrawi, Gamal Eltagy, Mohamed Qinawy, Mohammed Am Oshi, Amjad Algethami, Nawaf A Alhujayri, Shaker S Alharthi, Abdullah M Alelyani, Naglaa M Kamal

    Published 2025-02-01
    “…Extrahepatic biliary atresia (EHBA) is a leading cause of neonatal cholestasis, often resulting in end-stage cirrhosis and portal hypertension without early diagnosis and treatment. …”
    Get full text
    Article
  3. 343

    An Optimal Algorithm for Determining Risk Factors for Complex Diseases: Depressive Disorder, Osteoporosis, and Fracture in Young Patients with Breast Cancer Receiving Curative Surg... by Chieh-Yu Liu, Chun-Hung Chang

    Published 2018-01-01
    “…Among the risk factors identified using this novel algorithm, liver cirrhosis and COPD have been rarely mentioned in the literature. …”
    Get full text
    Article
  4. 344

    The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence by Kamran Qureshi, Shyam Patel, Andrew Meillier

    Published 2016-01-01
    “…Thrombocytopenia of cirrhosis is multifactorial in origin, and decreased activity of thrombopoietin has been identified to be a major cause. …”
    Get full text
    Article
  5. 345

    Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients by Maja Mijic, Ivona Saric, Bozena Delija, Milos Lalovac, Nikola Sobocan, Eva Radetic, Dora Martincevic, Tajana Filipec Kanizaj

    Published 2022-01-01
    “…Up to 40% of patients have an incomplete response to therapy, and over time disease progresses to liver cirrhosis. Several risk scores are proposed for better evaluation of patients before and during treatment to stratify patients at increased risk of disease progression. …”
    Get full text
    Article
  6. 346

    Efficacy of hepatitis B vaccination in patients awaiting liver transplantation in prophylaxis of <i>de novo</i> HBV-infection of a graft by V. Ye. Syutkin, O. I. Andreytseva, A. A. Saliyenko, A. V. Chzhao

    Published 2010-04-01
    “…Results of vaccination against hepatitis B in 41 patients with liver cirrhosis included into the Waiting list for orthotopic liver transplantation (OLT), and dynamics of HBV seromarkers in 72 patients before and after liver transplantation were analyzed.Results. …”
    Get full text
    Article
  7. 347

    Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection by Ignatius Y. S. Tang, Natasha Walzer, Nidhi Aggarwal, Ivo Tzvetanov, Scott Cotler, Enrico Benedetti

    Published 2011-01-01
    “…Renal transplant candidates with serologic evidence of HCV infection should undergo a liver biopsy to assess for fibrosis and cirrhosis. Patients with Metavir fibrosis score ≤3 and compensated cirrhosis should be evaluated for interferon-based therapy. …”
    Get full text
    Article
  8. 348

    Wilson – Konovalov Disease: Clinical Cases with Different Manifestations and Outcomes by O. V. Samodova, G. P. Smirnova, E. A. Krieger

    Published 2023-06-01
    “…Laboratory and instrumental examination enabled to diagnose Wilson – Konovalov disease at the stage of liver cirrhosis. The diagnosis was confirmed at the Federal medical center. …”
    Get full text
    Article
  9. 349

    The theses for MD degree by article Editorial

    Published 2012-11-01
    “…Yaroshenko – Comparative clinical characteristic of liver cirrhosis of various etiology.O.G. Stepanov – Regulatory disorders in pathogenesis of irritable bowel syndrome in children.…”
    Get full text
    Article
  10. 350

    Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C by Hala O. El-Mesallamy, Nadia M. Hamdy, Hanan H. Rizk, Abdel-Rahman El-Zayadi

    Published 2011-01-01
    “…Apelin; endogenous ligand for the orphan receptor APJ, was recently suggested to be associated with fibrosis progression and cirrhosis in addition to insulin resistance (IR) and inflammation. …”
    Get full text
    Article
  11. 351

    Microbial Translocation in Chronic Liver Diseases by Marilia Rita Pinzone, Benedetto Maurizio Celesia, Michele Di Rosa, Bruno Cacopardo, Giuseppe Nunnari

    Published 2012-01-01
    “…Furthermore, MT has been implicated in the pathogenesis of the complications of cirrhosis, which are a significant cause of morbidity and mortality in cirrhotic subjects. …”
    Get full text
    Article
  12. 352
  13. 353

    Gambaran Kadar Trombosit, Besar Limpa dan Kadar Albumin Serum pada Pasien Sirosis Hati dengan Varises Esofagus by Vella Paraditha, Saptino Miro, Eti Yerizel

    Published 2016-09-01
    “…The </em><em>objective</em><em> of this study was to recognize platelet count, spleen size and serum albumin level of liver cirrhosis patient in each esophageal varices degree. …”
    Get full text
    Article
  14. 354

    Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients by Jian-Wei Zhang, Kamran Ullah, Nauman Khan, Hai-Tao Pan

    Published 2025-01-01
    “…Abstract Pediatric non-alcoholic fatty liver disease (NAFLD) is emerging as a worldwide health concern with the potential to advance to cirrhosis and liver cancer. NAFLD can also directly contribute to heart problems through inflammation and insulin resistance, even in individuals without other risk factors. …”
    Get full text
    Article
  15. 355

    Vasopressin Antagonists and Dilutional Hyponatremia by D Mohamed Babatin, Samuel S Lee

    Published 2004-01-01
    “…The paradox of dilutional hyponatremia, as described by Ovid two millennia ago, continues to apply to patients with advanced cirrhosis today: they have unremitting thirst despite vastly increased total body water. …”
    Get full text
    Article
  16. 356

    Sonoclot Signature Analysis in Patients with Liver Disease and Its Correlation with Conventional Coagulation Studies by Priyanka Saxena, Chhagan Bihari, Archana Rastogi, Savita Agarwal, Lovkesh Anand, Shiv Kumar Sarin

    Published 2013-01-01
    “…Clinical and laboratory data from fifty inpatients of four subgroups of liver disease, including decompensated cirrhosis, chronic hepatitis, cirrhosis with HCC and acute-on-chronic liver failure were analyzed. …”
    Get full text
    Article
  17. 357

    Liver and spleen elastography in diagnosis of extrahepatic portal vein obstruction: pilot study by M. Yu. Nadinskaya, Ye. O. Liusina, Ch. S. Pavlov

    Published 2018-08-01
    “…The study group: 19 patients (Age 21-76 years) with PVT diagnosed by multispiral computed angiography without liver/pancreatobiliary tumors and/or liver cirrhosis (LC). The comparison group included 23 patients with LC Child-Pugh class A. …”
    Get full text
    Article
  18. 358

    The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study by Michael P. Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanien, Nezam H. Afdhal

    Published 2024-01-01
    “…Imaging-based noninvasive testing for liver fibrosis/cirrhosis is more accurate and is becoming more widespread. …”
    Get full text
    Article
  19. 359

    Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication by Anna Lang, Cameron Goff, Ashley Montgomery, Jake Lynn, Spoorthi Kamepalli, John Goss, Abbas Rana

    Published 2023-01-01
    “…Hepatoblastoma (hazard ratio (HR): 3.73), autoimmune cirrhosis (HR: 1.86), and AHN (HR: 1.77) were associated with significantly increased intent-to-treat mortality. …”
    Get full text
    Article
  20. 360

    Effects of Late Evening Snack on Cirrhotic Patients: A Systematic Review and Meta-Analysis by Ying-jie Guo, Zi-bin Tian, Na Jiang, Xue-li Ding, Tao Mao, Xue Jing

    Published 2018-01-01
    “…In this meta-analysis, we reviewed and quantified the effects of LES on energy metabolism and substrate oxidation in the patients with cirrhosis, which will be of benefit for liver cirrhosis nutritional therapy. …”
    Get full text
    Article